Unlocking life-saving
treatments potential
Methinks vision is to provide universal and timely diagnosis to enable life-saving treatments worldwide. Our first focus is on stroke, the second cause of death and a major cause of disability in the world.
Our AI software is a tool to diagnose stroke and assess life-saving treatments only from non-contrast CT, bypassing the need of a contrast CT and reducing time-to-treatment.
Basic stroke
assessment
Available in every hospital worldwide
Stage 1
Neurological
exploration
Stage 2
Non-contrast
CT scan
Advanced stroke
assessment
not available 24/7 in +50% hospitals worldwide
Stage 3
Contrast
CT scan
+54 min
Saving in hospitals not capable to perform advanced stroke assessment
+36 min
Saving in hospitals capable to perform advanced stroke assessment
Stage 4
Endovascular
Treatment
Methinks
Time Reduction
Basic stroke assessment
Available in every hospital worldwide
Stage 1
Neurological exploration
Stage 2
Non-contrast CT scan
Methinks
Time Reduction
+54 min
Saving in hospitals not capable to perform advanced stroke assessment
+36 min
Saving in hospitals capable to perform advanced stroke assessment
Advanced stroke
assessment
not available 24/7 in +50% hospitals worldwide
Stage 3
Contrast CT scan
Stage 4
Endovascular Treatment
Methinks artificial intelligence software is a tool to diagnose stroke and assess lifesaving treatments using only non-contrast CT.

By bypassing the need of a contrast CT, Methinks reduces "time to treatment" drastically.
Stroke Patient
Basic stroke assessment
Available in every hospital worldwide
+ Neurological exploration
+ Non-contrast CT scanner
Methinks solution
+1 hour
saving in hospitals not capable to perform advanced stroke assessment
+30 min
saving in hospitals capable to perform advanced stroke assessment
Endovascular Treatment
Advanced stroke assessment
Not available 24/7 in +50% hospitals worldwide4
+ Contrast CT scanner
Every patient will have access to the most effective treatment available. Every radiologist will perform the quickest assessment possible.
Current stroke treatment assessment leverages in advanced medical imaging. However, it is not always available in every hospital 24/7 and time-to-treatment is often delayed.
Methinks empowers any radiologist on the globe to assess stroke treatment from a simple neurological exploration and a non-contrast CT and will allow to coordinate any hospital with the nearest Stroke Unit.
Methinks is a seamless solution capable of
Detecting Large Vessels Occlusions
Large Vessel Occlusions can not be easily diagnosed from a non-contrast CT and require contrast medical imaging or MRI prior to perform an Endovascular Treatment. This, however, increases time-to-treatment and can worsen patient outcomes.
Detecting Hemorrhages
Some hemorrhages are easy to see but other might escape to human inspection. Not missing an hemorrhage is pivotal to asses if a patient can receive a trombolysis treatment or not.
Providing a cloud based communication system
Coordination among hospitals, Stroke Units and Healthcare Professionals can be extremely complex. Clinical decisions could be made much faster and resources could be used more efficiently.
Being the most cost effective
Healthcare systems suffer from severe costs but yet need to provide the best services possible. An accessible diagnosis tool at an affordable price can be decisive to improve healthcare treatments.
Methinks is actively collaborating with leading clinicians and industry experts globally. We want to share efforts with you too!
Please contact us
As a clinician with the dual perspective of a vascular neurologist and neurointerventionalist I am increasingly convinced that the simplest and fastest imaging modalities used to select acute stroke patients for thrombectomy are the ones most clinically beneficial. Methinks, the first company whose vision is to  develop this concept into a clinically established  paradigm is backed by unique technology and an outstanding team and has the potential to disrupt acute stroke systems of care.
Tudor Jovin
Chairman and Chief of Neurology at Cooper University Healthcare, New Jersey
Methinks AI permite o diagnostico o mais precoce possivel para a indicação de trombectomia em AVC. Eficiência essencial quando cada segundo que passa faz a diferença na vida de nossos pacientes.
Demetrius Lopes
Director Stroke Network Advocate Aurora Health, US
Methinks is already working for research purposes at Hospital Vall d'Hebron. The results we are seeing are outstanding and make us optimistic about the future of this technology.
Marc Ribó
Stroke Neurologist, and Interventionalist, Hospital Vall d'Hebron, Barcelona
With the support of
Hospitals
No items found.